(lp0
S"Threshold Pharmaceuticals and Molecular Templates Agree to Combine GlobeNewswire  - Mar 17, 2017 SOUTH SAN FRANCISCO, Calif. and AUSTIN, Texas, March 17, 2017  -- Threshold Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing novel therapies for cancer, and Molecular Templates,&nbsp;...Friday's Market Insights: Threshold Pharmaceuticals, Inc. , Innocoll ... - Smarter AnalystThreshold Pharmaceuticals, Molecular Templates to Merge - Genetic Engineering & Biotechnology News "
p1
aS'Threshold Pharmaceuticals To Become Molecular Templates Inc. After Merger Seeking Alpha - Mar 20, 2017 On March 16, Threshold and Molecular Templates announced their merger, to be called Molecular Templates Inc., once the deal closes.What Does The Merger News Mean For Threshold Pharmaceuticals Inc (NASDAQ:THLD ... - Insider FinancialThreshold Pharmaceuticals Inc.  hit its 52 Week low of $0.3 on May 9, 2016 - The Newburgh Press'
p2
aS'BRIEF-Threshold Pharmaceuticals and Molecular Templates agree to combine Reuters - Mar 17, 2017 March 17 Threshold Pharmaceuticals Inc. * Threshold Pharmaceuticals and Molecular Templates agree to combine. * Threshold Pharmaceuticals Inc says combined company will be capitalized to support advancement of MT-3724. * Longitude Capital will&nbsp;...'
p3
aS'Caris Life Sciences and Threshold Pharmaceuticals Collaborate to Utilize Caris ... PR Newswire  - Oct 25, 2016 IRVING, Texas and SOUTH SAN FRANCISCO, Calif., Oct. 25, 2016 /PRNewswire/ -- Caris Life Sciences, a leading biotechnology company focused on fulfilling the promise of precision medicine, and Threshold Pharmaceuticals, Inc. ,&nbsp;...'
p4
aS'Threshold Pharmaceuticals posts 4Q loss Yahoo Finance - Mar 27, 2017  _ Threshold Pharmaceuticals Inc.  on Monday reported a fourth-quarter loss of $3.7 million, after reporting a profit in the same period a year earlier.THRESHOLD PHARMACEUTICALS, INC.  Files An 8-K Results of ... - Market Exclusive'
p5
aS'Analysts Weigh in on Two Collapsing Biotech Stocks: Threshold Pharmaceuticals ... Smarter Analyst - Sep 30, 2016 The biotech world is experiencing volatility in the midst of a drug development discontinuation for Threshold Pharmaceuticals, Inc.  and word from the FDA to place a drug program on full clinical hold for Alcobra Ltd (NASDAQ:ADHD ...'
p6
aS'Threshold Pharmaceuticals: Twice Bitten, Thrice Shy? Seeking Alpha - Nov 28, 2016 Threshold Pharmaceuticals Inc  is a biopharmaceutical company in operation since the mid 2000s, with projects in the tumor/cancer treatment environment.'
p7
aS"Threshold Pharma  Says Two Studies Didn't Meet Activity Thresholds ... StreetInsider.com - Sep 29, 2016 On September 29, 2016, the Compensation Committee of the Board of Directors  of Threshold Pharmaceuticals, Inc.  committed to implementing a workforce reduction constituting approximately&nbsp;...Is There Value In The Threshold Pharmaceuticals, Inc.  Sell Off? - Market Exclusive"
p8
aS'Threshold Pharmaceuticals, Inc.  Might Just Have Become A Buyout ... Insider Financial - Oct 5, 2016 Threshold Pharmaceuticals, Inc.  collapsed last week on the announcement that its lead trial had missed its primary endpoint.'
p9
aS"Threshold Pharmaceuticals, Inc.  Releases Quarterly Earnings Results ... The Cerbat Gem - Apr 17, 2017 Threshold Pharmaceuticals logo Threshold Pharmaceuticals, Inc.  posted its earnings results on Monday. The biotechnology company reported  earnings per share  for the quarter, topping the Thomson Reuters' consensus&nbsp;..."
p10
a.